Literature DB >> 3708390

Morphine increases metastatic tumor growth.

R H Simon, T E Arbo.   

Abstract

Walker 256 carcinosarcoma cells produce subpleural pulmonary metastases when given intravenously to the Sprague-Dawley rat. The number of metastases increases when the rat is given morphine subsequent to the tumor load. The increase in the number of metastases can be blocked be pretreatment with the opiate antagonist naloxone. Naloxone itself does not influence the number of metastases. Pentazocine is an opiate that is agonistic to the endorphin kappa-type opiate receptor and partially antagonistic to the mu-type receptor, where morphine acts primarily. While pentazocine alone has no influence on metastases and may decrease the number when given early, pentazocine partially blocks the metastatic inducing effect of morphine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708390     DOI: 10.1016/0361-9230(86)90057-2

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  11 in total

Review 1.  Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.

Authors:  David Brinkman; Jiang H Wang; Henry P Redmond
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-20       Impact factor: 3.000

Review 2.  Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis.

Authors:  B Afsharimani; C W Doornebal; P J Cabot; M W Hollmann; M-O Parat
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC.

Authors:  Funda Ustun; Gülay Durmus-Altun; Semsi Altaner; Nermin Tuncbilek; Cem Uzal; Sakir Berkarda
Journal:  Med Oncol       Date:  2010-06-22       Impact factor: 3.064

4.  Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.

Authors:  Tamara King; Anna Vardanyan; Lisa Majuta; Ohannes Melemedjian; Ray Nagle; Anne E Cress; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2007-08-15       Impact factor: 6.961

5.  Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells.

Authors:  Xin Lin; Qing Li; Yu-Jun Wang; Ya-Wen Ju; Zhi-Qiang Chi; Min-Wei Wang; Jing-Gen Liu
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

Review 6.  The role of morphine in regulation of cancer cell growth.

Authors:  Katarzyna Gach; Anna Wyrębska; Jakub Fichna; Anna Janecka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-29       Impact factor: 3.000

7.  Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression.

Authors:  Sabrina Bimonte; Antonio Barbieri; Domenica Rea; Giuseppe Palma; Antonio Luciano; Arturo Cuomo; Claudio Arra; Francesco Izzo
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

8.  Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro.

Authors:  Weidong Wu; Ningxian Wei; Chun-Nan Jiang; Suyang Cui; Jintao Yuan
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

9.  Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Authors:  Long-Hui Cao; Hui-Ting Li; Wen-Qian Lin; Hong-Ying Tan; Lan Xie; Zhong-Jian Zhong; Jian-Hua Zhou
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

Review 10.  The role of morphine in animal models of human cancer: does morphine promote or inhibit the tumor growth?

Authors:  Sabrina Bimonte; Antonio Barbieri; Giuseppe Palma; Claudio Arra
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.